Author | Martin Sipkoff


IRS FSA rule trips up many retail pharmacies

December 11, 2009

Retail pharmacy managers are discovering that many third-party administrators do not agree that their inventory information approval systems meet compliance requirements set by the Internal Revenue Service for customers' use of flexible spending accounts.

Biogeneric drugs and brands: The future market share

October 08, 2009

When manufacture of biogenerics is a legal reality, brand manufacturers will still retain a strong market share for several years.

Wal-Mart, other discounters facing predatory-pricing concerns

April 02, 2007

When is $4 not $4? Apparently when it's the cost of a Wal-Mart generic in a state where the retail giant and its competitors may be violating predatory-pricing laws. Those laws ban selling products below cost in order to kill off competitors and may apply to prescription drug sales in 21 states, according to the National Conference of State Legislatures (NCSL) and the National Community Pharmacists Association.